{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:36:57Z","timestamp":1791355017801,"version":"4.3.1"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"name":"Research & Development Cell, Parul University","award":["CR4D-Dec-20124"],"award-info":[{"award-number":["CR4D-Dec-20124"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Anti-tubercular drug discovery is a critical research area aimed at addressing\nthe global health burden imposed by Mycobacterium tuberculosis. Nowadays, computational\ntechniques have increased the likelihood of drug development compared to traditional,\nlabor-intensive, and time-consuming drug design approaches. The pivotal goal of drug design is\nto identify compounds capable of selectively targeting protein, thereby disrupting its enzymatic\nactivity. InhA, or NADH-dependent enoyl-acyl carrier protein reductase, stands at the forefront\nof targeted approaches in the battle against TB. Isatin derivatives have garnered interest for their\ndiverse pharmacological activities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To identify novel isatin derivatives that could serve as potential chemical templates\nfor anti-TB drug discovery by targeting InhA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The present work utilized various computational approaches, including molecular\ndocking, binding free energy calculations, and conformational alignment studies to investigate\nthe binding mode and interactions of carefully selected dataset of 88 isatin derivatives within\nInhA active site. Study also employed MD simulations of the most promising molecule to check\nthe stability of the protein-ligand complex and in-silico ADMET profiling of the top compounds\nto predict their pharmacokinetic and toxicity properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Results provided insights into the structural features contributing to InhA inhibition,\nassessing overall drug-like characteristics of isatin derivatives and identified compound 48\n(BA= -10.4 kcal mol-1) with potential for further optimization. MD simulation analysis revealed\nthat compound 48 binds firmly within the InhA protein, exhibiting minimal conformational\nfluctuations and enhanced stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Considering the aforementioned, isatin derivatives represents a novel framework\nfor creating targeted InhA inhibitors during anti-TB therapy. However, experimental validations\nand in-depth analyses are crucial to confirm efficacy and safety of these derivatives as potential\nInhA inhibitors for TB treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734099333313240909103833","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T05:13:08Z","timestamp":1726463588000},"page":"226-254","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Computational Exploration of Isatin Derivatives for InhA Inhibition in Tuberculosis: Molecular Docking, MD Simulations and ADMET Insights"],"prefix":"10.2174","volume":"21","author":[{"given":"Vaishali Pavalbhai","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Quality Assurance, Parul Institute of Pharmacy and Research, Parul University, Vadodara, Gujarat,\n391760, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9699-4155","authenticated-orcid":true,"given":"Rati Kailash Prasad","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Sushruta School of Medical &amp; Paramedical Sciences, Assam University (A Central University), Silchar, 788011, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Dharamsi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, 391760, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/molecules25030665","volume":"25","author":"Macalino S.J.Y.","year":"2020","unstructured":"Macalino S.J.Y.; Billones J.B.; Organo V.G.; Carrillo M.C.O.; Constancia O.; In silico strategies in tuberculosis drug discovery. Molecules  2020,25(3),665","journal-title":"Molecules"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1016\/j.bmc.2004.09.017","volume":"12","author":"Monga V.","year":"2004","unstructured":"Monga V.; Nayyar A.; Vaitilingam B.; Palde P.B.; Singh Jhamb S.; Kaur S.; Singh P.P.; Jain R.; Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues. Bioorg Med Chem  2004,12(24),6465-6472","journal-title":"Bioorg Med Chem"},{"key":"ref=3","year":"2023","unstructured":"Global Tuberculosis report.  Available from:  https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-20232023"},{"key":"ref=4","first-page":"1284","volume":"31","author":"Oliveira J.R.S.","year":"2020","unstructured":"Oliveira J.R.S.; Shiguemoto C.Y.K.; Gomes G.B.; Perdomo R.T.; Barbosa S.L.; Croda J.; Baroni A.C.M.; das Neves A.R.; Guerrero Jr P.G.; Moreira F.M.F.; Design, synthesis and antitubercular activity of novel isoniazid-cyclic-amine-azachalcones hybrids. J Braz Chem Soc  2020,31,1284-1295","journal-title":"J Braz Chem Soc"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1590\/S0100-40422005000400022","volume":"28","author":"Souza M.V.N.","year":"2005","unstructured":"Souza M.V.N.; Vasconcelos T.R.A.; Drugs to combat tuberculosis: Past, present and future. Quim Nova  2005,28(4),678-682","journal-title":"Quim Nova"},{"key":"ref=6","unstructured":"Available from:  https:\/\/tbfacts.org\/new-tb-drugs\/"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jfluchem.2016.01.011","volume":"183","author":"Nayak N.","year":"2016","unstructured":"Nayak N.; Ramprasad J.; Dalimba U.; Synthesis and antitubercular and antibacterial activity of some active fluorine containing quinoline\u2013pyrazole hybrid derivatives. J Fluor Chem  2016,183,59-68","journal-title":"J Fluor Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"Corbett E.L.","year":"2003","unstructured":"Corbett E.L.; Watt C.J.; Walker N.; Maher D.; Williams B.G.; Raviglione M.C.; Dye C.; The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med  2003,163(9),1009-1021","journal-title":"Arch Intern Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.me.36.020185.002225","volume":"36","author":"Greenblatt D.J.","year":"1985","unstructured":"Greenblatt D.J.; Elimination half-life of drugs: Value and limitations. Annu Rev Med  1985,36(1),421-427","journal-title":"Annu Rev Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4920209","volume":"2017","author":"Nasiruddin M.","year":"2017","unstructured":"Nasiruddin M.; Neyaz M.K.; Das S.; Nanotechnology-based approach in tuberculosis treatment. Tuberc Res Treat  2017,2017,1-12","journal-title":"Tuberc Res Treat"},{"key":"ref=11","first-page":"318","volume":"6","author":"Vandana K.","year":"2017","unstructured":"Vandana K.; Marathakam A.; Thushara B.S.; Rajitha K.; A review on isatin derivatives with diverse biological activities. World J Pharm Res  2017,6(16),318-332","journal-title":"World J Pharm Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","volume":"28","author":"Xu Z.","year":"2017","unstructured":"Xu Z.; Zhang S.; Gao C.; Fan J.; Zhao F.; Lv Z.S.; Feng L.S.; Isatin hybrids and their anti-tuberculosis activity. Chin Chem Lett  2017,28(2),159-167","journal-title":"Chin Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/jhet.3189","volume":"55","author":"Jiang D.","year":"2018","unstructured":"Jiang D.; Wang G.Q.; Liu X.; Zhang Z.; Feng L.S.; Liu M.L.; Isatin derivatives with potential antitubercular activities. J Heterocycl Chem  2018,55(6),1263-1279","journal-title":"J Heterocycl Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s10904-023-02666-0","volume":"33","author":"Bugalia S.","year":"2023","unstructured":"Bugalia S.; Dhayal Y.; Sachdeva H.; Kumari S.; Atal K.; Phageria U.; Saini P.; Gurjar O.P.; Review on Isatin- A remarkable scaffold for designing potential therapeutic complexes and its macrocyclic complexes with transition metals. J Inorg Organomet Polym Mater  2023,33(7),1782-1801","journal-title":"J Inorg Organomet Polym Mater"},{"key":"ref=15a","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.8284673","volume":"263","author":"Banerjee A.","year":"1994","unstructured":"Banerjee A.; Dubnau E.; Quemard A.; Balasubramanian V.; Um K.S.; Wilson T.; Collins D.; de Lisle G.; Jacobs W.R.; inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis . Science  1994,263(5144),227-230","journal-title":"Science"},{"key":"ref=15b","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1080\/07391102.2018.1465852","volume":"37","author":"Modi P.","year":"2019","unstructured":"Modi P.; Patel S.; Chhabria M.T.; Identification of some novel pyrazolo[1,5- a ]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking. J Biomol Struct Dyn  2019,37(7),1736-1749","journal-title":"J Biomol Struct Dyn"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","volume":"18","author":"Takayama K.","year":"2005","unstructured":"Takayama K.; Wang C.; Besra G.S.; Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis . Clin Microbiol Rev  2005,18(1),81-101","journal-title":"Clin Microbiol Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/358591a0","volume":"358","author":"Zhang Y.","year":"1992","unstructured":"Zhang Y.; Heym B.; Allen B.; Young D.; Cole S.; The catalase\u2014peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis . Nature  1992,358(6387),591-593","journal-title":"Nature"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20062100","volume":"204","author":"Wang F.","year":"2007","unstructured":"Wang F.; Langley R.; Gulten G.; Dover L.G.; Besra G.S.; Jacobs W.R.; Sacchettini J.C.; Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med  2007,204(1),73-78","journal-title":"J Exp Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","volume":"15","author":"He X.","year":"2007","unstructured":"He X.; Alian A.; Ortiz de Montellano P.R.; Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorg Med Chem  2007,15(21),6649-6658","journal-title":"Bioorg Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem  2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem  2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"Eberhardt J.","year":"2021","unstructured":"Eberhardt J.; Santos-Martins D.; Tillack A.F.; Forli S.; AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. J Chem Inf Model  2021,61(8),3891-3898","journal-title":"J Chem Inf Model"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"Lu C.","year":"2021","unstructured":"Lu C.; Wu C.; Ghoreishi D.; Chen W.; Wang L.; Damm W.; Ross G.A.; Dahlgren M.K.; Russell E.; Von Bargen C.D.; Abel R.; Friesner R.A.; Harder E.D.; OPLS4: Improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput  2021,17(7),4291-4300","journal-title":"J Chem Theory Comput"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jcc.20292","volume":"26","author":"Banks J.L.","year":"2005","unstructured":"Banks J.L.; Beard H.S.; Cao Y.; Cho A.E.; Damm W.; Farid R.; Felts A.K.; Halgren T.A.; Mainz D.T.; Maple J.R.; Murphy R.; Philipp D.M.; Repasky M.P.; Zhang L.Y.; Berne B.J.; Friesner R.A.; Gallicchio E.; Levy R.M.; Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem  2005,26(16),1752-1780","journal-title":"J Comput Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1021\/ct700053u","volume":"3","author":"Nutt D.R.","year":"2007","unstructured":"Nutt D.R.; Smith J.C.; Molecular dynamics simulations of proteins:Can the explicit water model be varied? J Chem Theory Comput  2007,3(4),1550-1560","journal-title":"J Chem Theory Comput"},{"key":"ref=26a","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=26b","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"Pires D.E.V.","year":"2015","unstructured":"Pires D.E.V.; Blundell T.L.; Ascher D.B.; pkCSM: predicting small-molecules pharmacokinetic properties using graph-based signatures. J Med Chem  2015,58(9),4066-4072","journal-title":"J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1093-3263(02)00204-8","volume":"21","author":"Bostr\u00f6m J.","year":"2003","unstructured":"Bostr\u00f6m J.; Greenwood J.R.; Gottfries J.; Assessing the performance of OMEGA with respect to retrieving bioactive conformations. J Mol Graph Model  2003,21(5),449-462","journal-title":"J Mol Graph Model"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.matchemphys.2010.05.035","volume":"123","author":"Singh A.K.","year":"2010","unstructured":"Singh A.K.; Quraishi M.A.; Investigation of adsorption of isoniazid derivatives at mild steel\/hydrochloric acid interface: Electrochemical and weight loss methods. Mater Chem Phys  2010,123(2-3),666-677","journal-title":"Mater Chem Phys"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jhet.5570210614","volume":"21","author":"Popp F.D.","year":"1984","unstructured":"Popp F.D.; Potential anticonvulsants. IX. Some isatin hydrazones and related compounds. J Heterocycl Chem  1984,21(6),1641-1645","journal-title":"J Heterocycl Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1246\/bcsj.74.873","volume":"74","author":"Somogyi L.","year":"2001","unstructured":"Somogyi L.; Transformation of isatin 3-acylhydrazones under acetylating conditions: Synthesis and structure elucidation of 1,5\u2032-disubstituted 3\u2032-acetylspiro[oxindole-3,2\u2032-[1,3, 4]oxadiazolines]. Bull Chem Soc Jpn  2001,74(5),873-881","journal-title":"Bull Chem Soc Jpn"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/molecules13092126","volume":"13","author":"Bekircan O.","year":"2008","unstructured":"Bekircan O.; Bektas H.; Synthesis of Schiff and Mannich bases of isatin derivatives with 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones. Molecules  2008,13(9),2126-2135","journal-title":"Molecules"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0014-827X(99)00075-0","volume":"54","author":"Pandeya S.N.","year":"1999","unstructured":"Pandeya S.N.; Sriram D.; Nath G.; De Clercq E.; Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine. Farmaco  1999,54(9),624-628","journal-title":"Farmaco"},{"key":"ref=33","first-page":"217","volume":"7","author":"Aboul-Fadl T.","year":"2015","unstructured":"Aboul-Fadl T.; Abdel-Hamid M.K.; Youssef A.F.; Schiff bases of indoline-2, 3-dione (isatin) derivatives as efficient agents against resistant strains of Mycobacterium tuberculosis. Der Pharma Chem  2015,7,217-225","journal-title":"Der Pharma Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.3390\/molecules16097864","volume":"16","author":"Aboul-Fadl T.","year":"2011","unstructured":"Aboul-Fadl T.; Abdel-Aziz H.A.; Abdel-Hamid M.K.; Elsaman T.; Thanassi J.; Pucci M.J.; Schiff bases of indoline-2,3-dione: potential novel inhibitors of Mycobacterium tuberculosis (Mtb) DNA gyrase. Molecules  2011,16(9),7864-7879","journal-title":"Molecules"},{"key":"ref=35","first-page":"342","volume":"3","author":"Haider S.","year":"2014","unstructured":"Haider S.; Saify Z.S.; Naz A.; Fizza K.; Tabina Z.M.; Arain A.; Rao T.A.; Ashraf S.; Ghaffar A.; Synthesis and conformational studies of N\u2032-(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-3-carbohydrazide with specific pharmacophoric features. World J Pharm Res  2014,3(7),342-351","journal-title":"World J Pharm Res"},{"key":"ref=36","first-page":"2338","volume":"5","author":"Al-Kadhimi A.A.","year":"2015","unstructured":"Al-Kadhimi A.A.; Al-Azzawi N.K.; Khalaf A.I.; Facile synthesis of Schiff and Mannich bases of isatin derivatives. J Chem Biol Phys Sci  2015,5(3),2338-2349","journal-title":"J Chem Biol Phys Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF02974237","volume":"17","author":"Ali S.","year":"1994","unstructured":"Ali S.; Alam M.; Potential antimicrobial agents-I: Structural modifications and antimicrobial activity of some isatin derivatives. Arch Pharm Res  1994,17(2),131-133","journal-title":"Arch Pharm Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4236\/ijoc.2019.91004","volume":"9","author":"Bawazir W.A.B.","year":"2019","unstructured":"Bawazir W.A.B.; Synthesis of some new thioethers and 4-thiazolidinones bearing 3-(pyridine-4\u2032-yl)-1,2,4-triazino [5,6-b]indole moiety as antifungal agents. Int J Org Chem (Irvine)  2019,9(1),37-46","journal-title":"Int J Org Chem (Irvine)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","volume":"101","author":"Lipinski C.A.","year":"2016","unstructured":"Lipinski C.A.; Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev  2016,101,34-41","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"Veber D.F.","year":"2002","unstructured":"Veber D.F.; Johnson S.R.; Cheng H.Y.; Smith B.R.; Ward K.W.; Kopple K.D.; Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem  2002,45(12),2615-2623","journal-title":"J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s42250-020-00161-4","volume":"3","author":"Olasupo S.B.","year":"2020","unstructured":"Olasupo S.B.; Uzairu A.; Adamu G.S.; Uba S.; Computational modeling and pharmacokinetics\/ADMET study of some arylpiperazine derivatives as novel antipsychotic agents targeting depression. Chemistry Africa  2020,3(4),979-988","journal-title":"Chemistry Africa"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"Daina A.","year":"2016","unstructured":"Daina A.; Zoete V.; A boiled-egg to predict gastrointestinal absorption and brain penetration of small moelcules. ChemMedChem  2016,11(11),1117-1121","journal-title":"ChemMedChem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/07391102.2020.1815579","volume":"40","author":"Hassan S.S.","year":"2022","unstructured":"Hassan S.S.; Zhang W.D.; Jin H.; Basha S.H.; Priya S.V.S.S.; In-silico anti-inflammatory potential of guaiane dimers from Xylopia vielana targeting COX-2. J Biomol Struct Dyn  2022,40(1),484-498","journal-title":"J Biomol Struct Dyn"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099333313240909103833","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234044\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099333313240909103833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:58:39Z","timestamp":1739433519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234044\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734099333313240909103833","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}